No registrations found.
ID
Source
Brief title
Sponsors and support
the Netherlands
the Netherlands
Intervention
Outcome measures
Primary outcome
Average pain reduction measured by numeric rating scale during the study period.
Secondary outcome
Effect of the interventions after 2, 4 and 8 weeks at:
1. Adherence to ATC analgesics;
2. Worst pain reduction;
3. Average pain reduction;
4. Present pain reduction;
5. Proportion of patients with clinically relevant pain reduction;
6. Pain interference;
7. Quality of life;
8. Reduction of side effects;
9. Adequacy of pain treatment;
10. Pain knowledge.
Background summary
Patients with advanced cancer experience multiple symptoms. Among these symptoms pain is the most prevalent and feared: 15 – 77% of cancer patients experience pain. Although adequate pain treatment is now available for most patients, data have demonstrated that these methods are not used to their fullest, leading to inadequate pain relief in 42-65% patients. Pain management could be influenced by various factors, e.a. cause of pain, analgesics prescription, side effects and adherence. Physicians’ knowledge about pain, pain management and analgesics could affect patients pain, but patients’ misconceptions and beliefs could also influence the adequacy of pain management. To study which intervention would be most effective in reducing average pain intensity, patients will be randomised to:
1. standard care;
2. pain consult;
3. pain consult in combination with pain education.
Study objective
It is hypothised that a pain consult at the specialized pain clinic in combination with Patient Education Program is more effective in reducing average pain intensity compared to a pain consult alone. A pain consult at the specialized pain clinic is more effective in reducing average pain intensity compared to standared care.
Study design
N/A
Intervention
1. Second opinion pain consult at the specialist pain clinic;
2. Second opinion pain consult combined with Pain Education Program and monitoring by nurse specialists.
W.H. Oldenmenger
Rotterdam 3008 AE
The Netherlands
+31 (0)10 4391439
w.h.oldenmenger@erasmusmc.nl
W.H. Oldenmenger
Rotterdam 3008 AE
The Netherlands
+31 (0)10 4391439
w.h.oldenmenger@erasmusmc.nl
Inclusion criteria
1. Cancer-related pain or cancer treatment related pain for at least two weeks;
2. Nociceptive pain;
3. Average pain intensity score of 4 or more;
4. Accessibility by telephone;
5. A life expectancy of at least three months;
6. Informed consent.
Exclusion criteria
1. Neuropathic pain;
2. Residing in nusing home or retirement home;
3. Pain not treated with oral medication;
4. Radiotherapy in the past two weeks.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| NTR-new | NL557 |
| NTR-old | NTR613 |
| Other | : EMC 2005 - 257 |
| ISRCTN | ISRCTN68236655 |